Business Wire

Andersen Global Announces New Board of Directors for Europe

Del

Andersen Global named the members of the European Regional Board of Directors. This regional board will advise the global organization on issues critical to the continent to ensure that the group is working in a seamless way across the different countries of the region, practice areas, industries and also on the management of common protocols.

The European Regional Board of Directors, led by Co-Managing Partners for the European Region, Andrea De Vecchi and Paolo Mondia, will develop the strategy for the region and also participate in its implementation. The board is comprised of 14 top tax and legal Partners from Andersen Global member firms and five from collaborating firms, who will collaborate closely with Andersen Global Chairman and Andersen Tax LLC CEO, Mark Vorsatz, to consider and provide guidance on direction and operations in Europe.

The announcement of the EU Regional Board today at its first meeting in Portugal signals Andersen Global’s major expansion through Europe over the past four years, having added presence in several major economic hubs, including the United Kingdom, Germany, Portugal, France, Spain, Italy, Hungary, Turkey, Ireland, Austria, Poland, Greece, Cyprus, Luxembourg, Slovakia, the Netherlands and Switzerland, through its member firms and collaborating firms.

“We are proud of Andersen Global’s growth in Europe and have experienced an increase in clients demanding cross border services. Now is the time to implement a common governing group that will bring all the members in our region together in a coordinated way,” said Andrea De Vecchi. “In March of 2017, Andersen Global had 57 locations worldwide and today we have over 110. In the past year we added a new presence in Europe in significant markets such as the United Kingdom. But the most important thing about this growth is that we all share the same vision and core values regardless of location.”

Paolo Mondia added, “We truly believe that creating a supportive and rewarding environment that also helps every member of the firm to work closely with other offices, as well as participate in common training programs, will help in the knowledge-exchange between the different countries. The European Board of Directors will support this determination.”

The members of the new European Regional Board of Directors have significant reputations as leaders in their respective markets and industries. The members are:

  • Andrea De Vecchi, Regional Managing Director for Europe (Milan) – Co-Chair
  • Paolo Mondia, Regional Managing Director for Europe (Lugano) – Co-Chair
  • Jean-Philippe Bindschedler, Office Managing Director/Partner at Andersen Tax in Switzerland (Lausanne)
  • Pierre Bouley, Managing Director/Partner at Andersen Tax & Legal in France (Paris)
  • Mark Gorman, Office Managing Director/Partner at Andersen Tax in Ireland (Dublin)
  • Luis Nobre Guedes, Office Managing Director/Partner at Andersen Tax & Legal in Portugal (Lisbon)
  • Stefan Kraus, Office Managing Director/Partner at Andersen Tax & Legal in Germany (Cologne)
  • George McCracken, Managing Director/Partner at Andersen Tax LLP (London)
  • Ersin Nazali, Office Managing Director/Partner at Andersen Tax in Turkey (Istanbul)
  • Toni Prat, Office Managing Director/Partner at Andersen Tax & Legal in Spain (Barcelona)
  • Michael Probst, Office Managing Director/Partner at Andersen Tax in Luxembourg (Luxembourg City)
  • Alessio Rossi, Office Managing Director/Partner at Andersen Tax & Legal in Germany (Dusseldorf)
  • Paolo Trevisanato, Managing Director/Partner at Andersen Tax & Legal in Italy (Venice)
  • Ruben Van Aarle, Office Managing Director/Partner at Andersen Tax & Legal in the Netherlands ('s-Hertogenbosch)

In addition, the following collaborating firm Partners will contribute to the board as adjunct participants:

  • Marcin Matyka, Managing Director/Partner at A2Z Tax & Legal (Warsaw)
  • Nakis Kyprianou, Office Managing Director/Partner at UnityFour (Nicosia)
  • Nikos Siakantaris, Office Managing Director/Partner at UnityFour (Athens)
  • Karoly Radnai, Office Managing Director/Partner at OrienTax (Budapest)
  • Gabriel Lansky, Office Managing Director/Partner at Lansky (Vienna)

“Transparent and leading participatory management that represents the best interest of our Partners is extremely important to us,” said Mark Vorsatz. “We value the breadth of the experience of each of these board members as we seek to not only create a premier global firm with the absolute best-in-class service, but also grow and shape a global firm that will set these standards for generations.”

Andersen Global is an international association of legally separate, independent member firms comprised of tax and legal professionals around the world. Established in 2013 by U.S. member firm Andersen Tax LLC, Andersen Global now has more than 3,500 professionals worldwide and a presence in over 112 locations through its member firms and collaborating firms.

Contact information

Andersen Tax
Megan Tsuei, 415-764-2700

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Pioneering Project for Pharmaceutics – Vifor Pharma and the University of Basel are Jointly Establishing the World’s First Research Professorship for Nanopharmaceutical and Regulatory Science26.5.2019 07:00:00 CESTPressemelding

Nanopharmaceutics promises ground-breaking innovation in the development of medicines: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190526005014/en/ The Vifor Pharma Group is endowing two professorships for Nanopharmaceutical and Regulatory Science at the University of Basel The commitment by Vifor Pharma and the University of Basel is aimed at ensuring Switzerland has the specialist knowledge and equipment needed to compete globally in this important emerging area of life sciences With this decision, Vifor Pharma is demonstrating its commitment to Switzerland as a world-leading location for pharmaceutical research and development Nanomedicines are playing an increasingly important role in the development of innovative new medications. These drugs are able to overcome specific cellular barriers in the human body with a view to targeting their effect even more precisely. Nanopharmacy therefore promises to help advance medic

XINHUANET: Promotion Event of The Most Beautiful Shooting Location in China Held During Cannes Film Festival25.5.2019 18:20:00 CESTPressemelding

On May 16 (local time), an event was held at the 72nd Cannes Film Festival to recommend China’s most beautiful shooting locations on the theme of “Fascinating China.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190525005008/en/ The representative from Cannes Convention Bureau (1st L), Michel Chevillon (C), vice president of the French Riviera Chamber of Commerce and Industry and head of hotel association, and Adeline CHAUVEAU (3rd R), officer in charge of film and television projects from French Embassy to China, pose for a group photo with the representatives from the cities awarded for "The most beautiful shooting location in China." (Photo: Business Wire) In the event, the Yellow Sea National Forest Park in Dongtai, Jiangsu Province, the One Hundred Mile Azalea Forest in Bijie, Guizhou Province, Siming District of Xiamen, Fujian Province, and the Li Autonomous County in Lingshui, Hainan Province were on the list. The p

Knopp Biosciences Presents Positive Preclinical Data for Lead Neonatal Epilepsy Drug Candidate at 2019 Antiepileptic Drug and Device Trials XV Conference24.5.2019 14:00:00 CESTPressemelding

Knopp Biosciences LLC, a privately held drug discovery and development company focused on delivering breakthrough treatments for inflammatory and neurological diseases of high unmet need, today presented in vitro and in vivo data for the company’s lead molecule for the targeted treatment of KCNQ2-neonatal epileptic encephalopathy (KCNQ2-NEE) at the Antiepileptic Drug and Device Trials XV Conference in Miami, Florida. KCNQ2-NEE, a rare infant genetic epilepsy, results from mutations in genes encoding the Kv7.2/Kv7.3 ion channel, leading to frequent seizures and profound developmental delay. The preclinical data were presented by Steven Dworetzky, Ph.D., Knopp’s Chief Scientific Officer, a longtime Kv7 researcher who led the group that first cloned the Kv7.2 and Kv7.3 genes during his former tenure with the Bristol-Myers Squibb Co. Dr. Dworetzky presented results demonstrating the in vitro nanomolar activity of KB-3061 and its significant seizure protection in the maximal electroshock mo

Accelerate Your Business in South Korea Through 2019 K-Startup Grand Challenge24.5.2019 10:20:00 CESTPressemelding

Entrepreneurs from across the globe should set their sights on participating in the 2019 K-Startup Grand Challenge. Supported by the Ministry of SMEs and Startups and National IT Industry Promotion Agency (NIPA) of South Korea, the initiative provides invaluable support and comprehensive resources to early age startups. Applications for the K-Startup Grand Challenge are currently being accepted through June 14, 2019. In order to advance in the program, teams must pass a regional audition. A judging panel of startup ecosystem experts and Korean accelerators will select 40 teams to participate in an enriching 3.5 month-long acceleration program in Korea. The selected teams will have exclusive access to free office space at the Startup Campus in Pangyo Techno Valley, one-on-one mentoring, information sessions, coaching on Korean and Asian business culture and the chance to attend insightful seminars on accounting regulations to tax laws, patents and more. Opportunities for networking with

New Investigational Clinical Data for Ipsen’s Oncology Products in 11 Solid Tumor Types to Be Presented at 2019 ASCO Annual Meeting24.5.2019 05:00:00 CESTPressemelding

Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced that new data from clinical studies on investigational uses of cancer medicines cabozantinib (Cabometyx®), liposomal irinotecan (Onivyde®), and lanreotide autogel (Somatuline®, marketed as Somatuline Depot® in the United States) will be presented at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting. The meeting takes place in Chicago, Illinois, U.S., 31 May–4 June 2019; data featuring Ipsen medicines includes: New data from the Phase 3 CELESTIAL trial on the association of adverse events with efficacy outcomes for cabozantinib in patients with advanced hepatocellular carcinoma Overview of the Phase 3 COSMIC-312 trial of cabozantinib in combination with atezolizumab vs sorafenib in patients with advanced hepatocellular carcinoma who have not received previous systemic anticancer therapy First Phase 2 data from the CaboGIST study (trial 1317) from the European Organization for Research and Treatment of

The Posiflex Group Showcases an Ecosystem of Connected Solution Endpoints with IoT Remote Monitoring at Computex 201924.5.2019 01:00:00 CESTPressemelding

For the Computex 2019 show, The Posiflex Group is featuring leading solution technology from the family of brands as a fully Serviced IoT Ecosystem. Solution end points include: Connected Modular Kiosks, POS Terminals, and Digital Signage solutions from Posiflex and KIOSK Information Systems Smart Medical Displays with gesture controls from Portwell Connected Gaming Solutions with Player Tracking Technology from Portwell subsidiary, Ganlot The booth display is based on common field service endpoints represented in a European Manor Destination Resort setting. Field solutions for an array of vertical market applications include QSR ordering, cinema ticketing, fashion retail customer loyalty, interactive signage, hotel / medical center check-in and bill pay, as well as casino gaming technology. This year, in addition to their renowned POS product suite, Posiflex will be featuring newly introduced Modular Kiosk platforms (co-designed by KIOSK and Posiflex), which are configure-to-order sta